Darren Bustin and Paul Rayner offer an introduction to the Royal London Absolute Government Bond Fund, their investment process and philosophy.Read more >
London Mayor Boris Johnson is once again attending MIPIM - the biggest convention for the world's property market. Johnson will be speaking at the opening of the London Pavilion at MIPIM. This webcast will be a live stream of his speech.Read more >
Mark Boleat, Chairman of Policy & Resources, The City of London
Stephen Brown, Executive Chairman, GVA
Juliette Morgan, Head of Property, Tech City Investment Organisation
Colin Stanbridge, Chief Executive, London Chamber of Commerce and Industry
Nick Searl, Partner, Argent
Small businesses are a critical part of the national and London economy. They are agents of growth - especially in markets moving out of recession - with the capacity to boost employment and facilitate innovation.
Many of these businesses are clustering in and around East London. But is the space they need for growth available to anything like the extent required?
Which sectors – from TMT to financial services - will drive demand? What’s the future pipeline for space provision for SMEs in the City? What do SMEs want from landlords in order for them to be successful? How are landlords and developers responding? How is the City of London responding to these new demands? And what are the consequences for planning and development and for the future of the City and London in general?
Debate sponsored by GVA
Max James, Chief Executive, Quintain;
Stephen Down, Head of Central London and International, Savills
Ciaran Carvalho, Head of Real Estate, Nabarro LLP
Dermot Kiernan, UK Fund Manager, M&G Real Estate
London begun 2014 by being named the most attractive destination in the world for foreign investors. But the surge of international money into the capital has forced domestic investors to look further afield. With so many investors priced out of prime, is there still value in core London markets or is there only opportunity in the fringe?
Debate sponsored by Savills and Nabarro LLP
The Estates Gazette Question Time road show has been criss-crossing the UK and is now set to roll into London.
Please join us for this live debate being broadcast from The Shard, the capital’s most striking recent development and Western Europe’s tallest building, on Thursday 4th July as our expert panel gets to the heart of the industry's biggest issues.
· Irvine Sellar, Developer, London Bridge Quarter
· Mark Ridley, Chairman and Chief Executive, Savills UK
· Ian Lindsay, Land & Property Director, Crossrail
· Gavin Poole, CEO, iCITY
. Richard Dakin, Head of Corporate Real Estate Business Support, Lloyds Bank
. Simon Allford, Director, Allford Hall Monaghan Morris
. Andy Bruce, Head of London Real Estate, Linklaters
Asian money has flooded into commercial and residential property in London in recent years - from flats on the South Bank to trophy office buildings in the City. Where exactly is the money coming from? How can the capital ensure it remains an attractive place to live, study, work and invest? And how can the property industry help ward off macro economic threats to London's pull?Read more >
This presentation will provide a guide for IFAs to utilising ETFs on the London Stock Exchange. It will highlight the continuing development of these simple and flexible investment tools and identify the key drivers for the market's continuing growth and expansion. We will explore key trends in new product development and discuss what the future holds for this market.
Gillian Walmsley is Head of Fixed Income Products at the London Stock Exchange and covers the Group's London markets for ETFs, ETCs and ETNs in addition to Fixed Income & Securitised Derivatives.
Before joining the Exchange in 2008, Gillian was part of the Interest Rate product development team at Liffe, the derivatives arm of NYSE Euronext, where she worked on the design and launch of various short-term interest rate, bond index and government bond futures and options contracts and on the structuring of exchange credit derivatives.
Previously, she was part of the Equity Derivatives team and worked on the launch of stock futures, the development of the UK equity options market and the introduction of flexible equity and index contracts. Gillian began her career in the City on the Liffe trading floor as an Exchange Official overseeing open-outcry trading activity in the fixed income option pits.
A few weeks back, we heard from US recruiting thought leaders had to say about trends you cannot ignore and tools recruiters cannot live without in 2015.
It’s a brand new year -- the perfect time to evaluate your recruiting tool set. What worked in 2014, and what missed the mark? Our panel of dynamic UK recruitment executives will update you on the latest and greatest technology & services so you can continue to grow your talent pool, engage and nurture candidates, and surpass your growth goals in 2015.
Panel representatives from: Guy Rubin, CEO, ebsta; Clair Bush, Marketing Director, Broadbean EMEA; Katrina Collier, Recruitment Specialist, Winning Impression; Kirsten Pope, UK Account Manager, Burning Glass; Mark Seemann, CEO, Synety; and Ted Elliott, CEO, Jobscience.
Job Curtis, Manager, City of LondonRead more >
On 22nd September 2015, the Marketing Nation Roadshow came to London! Discover what the great thought leaders - attendees, speakers & organisers - thought of the event in this video, filmed on the show floor!Read more >
Job Curtis, Manager, City of LondonRead more >
London’s stock has soared on the international stage in recent years. More often than not the city is international investors’ first port of call when considering investing in European real estate. But is its supremacy assured? How much of a risk is the uncertain economic environment in the UK? And what can developers and advisers do to ensure inward investment continues to flow the capital’s way.Read more >
The Company’s objective is to provide long-term growth in income and capital, principally by investment in equities listed on the London Stock Exchange. The Board continues to recognise the importance of dividend income to shareholders.
Job will talk about how his portfolio is structured and his outlook for the coming months.
2016 is proving to be the year London Market Insurers concentrate on improving their technical pricing frameworks. Currently most models are run in Microsoft Excel with data being sent back to a relational database such as a SQL server.
During this webinar our host, David Hughes, will discuss the latest thinking around the underlying data model, with a particular focus on adopting noSQL databases. He will outline a typical pricing framework and the limitations of the most popular type of data model as well as providing an overview of noSQL databases, their individual merits and how best to apply them to solving the data model problem.
This webinar will be of interest to pricing actuaries, technology officers of insurers and underwriters involved in developing technical pricing frameworks.
Keith Wade, Chief Economist, offers his global economic outlook at the Schroders London Investment Conference.Read more >
Matt Hudson, Head of Business Cycle, offers his views on the UK equity market at the Schroders London Investment Conference.Read more >
James Sym, European Equities Fund Manager, discusses investing in a European recovery at the Schroders London Investment Conference.Read more >
Bob Jolly, Head of Global Macro, discusses whether the great bull market is over for bonds and if they still have a place in your portfolio, at the Schroders London Investment Conference.Read more >
Drug target validation is a major obstacle to drug development leading to high rates of late-stage failure because the pivotal study in drug development - the randomised trial – occurs at the end of the development pipeline.
Genetic studies using the principle of Mendelian randomisation reproduce key elements of a randomised trial ensuring target validation can take place earlier in development.
A second major obstacle in drug development is the understanding of individual differences in drug efficacy and safety due to naturally occurring variation in gene encoding proteins involved in drug disposition – a key component of stratified medicines research.
The Illumina Drug Development Array is designed to address issues and enable genomic discoveries to be used in drug development.
The array combines the genome-wide tag SNP content of the Illumina Human Core BeadChip (240,000 highly-informative genome-wide tag SNPs and over 20,000 high-value markers) with a novel 200,000 custom marker set designed to support studies of drug target validation and treatment response. The array is relevant to full range of human drug targets and medical disorders.
The webinar will:
- Introduce the concept of Mendelian randomisation studies for target selection and validation in drug development
- Discuss the concept of the ‘druggability’ and the ‘druggable genome’
- Describe development of the content of the Illumina drug development array based on an updated set of genes encoding druggable targets and the proteins involved in in drug absorption, distribution, metabolism and excretion (ADME)
- Prof. Aroon Hingorani, Chair of Genetic Epidemiology, Institute of Cardiovascular Science, University College London
- Prof. John Overington, Visiting Professor of Computational Chemical Biology, Institute of Cardiovascular Science, University College London
- Dr. Anna Gaulton, Senior Data Integration and Development Officer – ChEMBL, European Bioinformatics Institute, Hinxton
Simon Cocker , Royal London GroupRead more >